|
13-dihydrodaunorubicin |
|
CHEBI:31059 |
|
An aminoglycoside antibiotic that is (1S,3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene having a 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl residue attached at position 1 via a glycosidic linkage. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C27H31NO10/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33/h4-6,10-11,14,16-17,22,29-30,32,34-35H,7-9,28H2,1-3H3/t10-,11?,14-,16-,17-,22+,27-/m0/s1 |
HJEZFVLKJYFNQW-FKKRWUELSA-N |
COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)O |
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via anthracycline )
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via carbohydrate-containing antibiotic )
|
|
View more via ChEBI Ontology
(1S,3S)-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
|
1-Hydroxy-13-dihydrodaunomycin
|
ChemIDplus
|
13-Dihydrodaunomycin
|
ChemIDplus
|
Antibiotic 20-798RP
|
ChemIDplus
|
Daunomycinol
|
ChemIDplus
|
Daunorubicinol
|
ChemIDplus
|
Dihydrodaunomycin
|
ChemIDplus
|
Duborimycin
|
ChemIDplus
|
Leukaemomycin D
|
ChemIDplus
|
28008-55-1
|
CAS Registry Number
|
KEGG COMPOUND
|
28008-55-1
|
CAS Registry Number
|
ChemIDplus
|
6773802
|
Reaxys Registry Number
|
Reaxys
|
9098063
|
PubMed citation
|
Europe PMC
|
9864343
|
PubMed citation
|
Europe PMC
|
|